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Lupeol acetate as a potent 
antifungal compound 
against opportunistic human 
and phytopathogenic mold 
Macrophomina phaseolina
Shabnam Javed1,2,3, Zaid Mahmood1,4, Khalid Mohammed Khan2, Satyajit D. Sarker3, 
Arshad Javaid5, Iqra Haider Khan5 & Amna Shoaib 5*
Antifungal activity of Monotheca buxifolia methanolic extract and its various fractions were assessed 
against Macrophomina phaseolina, a soil-borne fungal pathogen of more than 500 vegetal species as 
well as rare and emerging opportunistic human pathogen. Different concentrations of methanolic 
extract (3.125 to 200 mg  mL−1) inhibited fungal biomass by 39–45%. Isolated n-hexane, chloroform 
and ethyl acetate fractions suppressed fungal biomass by 32–52%, 29–50% and 29–35%, respectively. 
Triterpenes lupeol and lupeol acetate (1, 2) were isolated from n-hexane while betulin, β-sitosterol, 
β-amyrin, oleanolic acid (3–6) were isolated from chloroform fraction. Vanillic acid, protocatechuic 
acid, kaempferol and quercetin (7–10) were isolated from the ethyl acetate fraction and identified 
using various spectroscopic techniques namely mass spectroscopy and NMR. Antifungal activity 
of different concentrations (0.0312 to 2 mg  mL−1) of the isolated compounds was evaluated and 
compared with the activity of a broad spectrum fungicide mancozeb. Different concentrations of 
mencozeb reduced fungal biomass by 83–85%. Among the isolated compounds lupeol acetate (2) 
was found the highest antifungal against M. phaseolina followed by betulin (3), vanillic acid (7), 
protocatechuic acid (8), β-amyrin (5) and oleanolic acid (6) resulting in 79–81%, 77–79%, 74–79%, 
67–72%, 68–71% and 68–71%, respectively. Rest of the compounds also showed considerable 
antifungal activity and reduced M. phaseolina biomass by 41–64%.
Macrophomina phaseolina is an important soil-borne plant pathogen that causes diseases over 500 plant species 
including economically important crops such as legumes, sunflower, cotton, sorghum and vegetables. Generally 
it causes charcoal rot disease in various crops; however, it also causes other diseases such as seedling and stem 
blight, damping off and  wilt1. It has vast distribution in tropical and subtropical countries, however, its exposure 
to human may cause infection in immunosuppressed patients. Several strategies are being adopted to control 
fungal plant pathogens by synthetic fungicides. No doubt, these fungicides are effective in controlling plant dis-
eases but they also pose severe hazards to human health and cause environmental pollution by accumulation in 
soil and  water2. It necessitates alternative environmental friendly strategies for management of phytopathogens. 
Many recent studies have shown that crude plant extracts as well as purified compounds isolated from various 
plant species are very effective in the control of fungal plant  pathogens3–5. Studies have shown that plant extracts 
of Chenopodium spp., Senna occidentalis and Cirsium arvense can control growth of M. phaseolina and charcoal 
rot of  mungbean6–10. From Azadirachta and Mango leaves, three flavonoids (–)-epi-catechin, (−)-epicatechin-
3-O-β-glucopyranoside and 6-(phydroxybenzyl)taxifolin-7-O-β-d-glucoside were isolated and found effective 
against M. phaseolina11,12.
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Monotheca buxifolia (Falc.) A. DC. is monotypic genus of the family Sapotacea, grows mainly in Malakand 
Dir district, Pakistan. M. buxifolia is reported for wide-range of pharmacological activities including cough, 
wound healing, headache, analgesic, antipyretic, antiseptic and urinary tract  infections13. The antibacterial activ-
ity of crude ethanolic extract and fractions of M. buxifolia using agar well diffusion technique confirmed their 
antibacterial  potential14. Javed et al.15 isolated and identified five triterpenes from the bioactive fractions of aerial 
parts of M. buxifolia and displayed potent cytotoxic activities in vitro. The other plants of family Sapotaceae are 
widely explored and reported for significant antimycotic activities in various experimental models, but there 
is not only a single report on antifungal activity and isolation of antifungal compounds from M. buxifolia16. 
Therefore, the present investigation was conducted to explore antifungal potential of M. buxifolia fractions 
and isolated compounds against M. phaseolina, a highly problematic phytopathogen for which there is not any 
registered fungicide up to now.
Results
Characteristic of the compounds. Compound 1. EI-MS m/z (relative intensity): 426(52)  [M]+, 
411(20), 393 (8), 218(42), 207(80), 189(100), 139(74). EIMS showed fragment peaks at m/z 411  [M+-CH3], 218 
 [M+-C14H20], 207(80) which are characteristic signals for pentacyclic triterpenes having isopropenyl group. 
HREI-MS m/z: 426.3820 (calcd. for  C30H50O, 426.3862). The 1H-NMR spectrum of 24 showed seven singlet for 
methyl protons at δ 0.74, 0.81, 0.85, 0.89, 0.91, 0.97 and 1.06 signals, one for each of seven methyl protons. A pair 
of multiplets at δ 4.20 and 4.21, each for H-29, identified the presence of terminal isopropenyl group, character-
istic of lupane series of triterpenoids. 13C NMR spectrum showed 30 signals for the triterpenoid lupane skeleton, 
including C-3 at δ 79.2 bonded to the hydroxyl group. Compound 1 was identified as  Lupeol19.
Compound 2. HREI-MS showed  [M]+ 468.3967 correlated with  C32H52O2 . EI-MS showed fragments 427 
 [M+—41], 408  [M+-AcOH], 249  [M+-C16H27] and 189  [M+-C16H27-AcOH]. 1H-NMR spectrum of 2 recorded 
seven tertiary methyl group at δ 0.76, 0.81, 0.83, 0.86, 0.92, 1.01, 1.31 and methyl acetate at 2.32. A pair of broad 
singlets at δ 4.47 and 4.44 showed presence of exomethylene group. A double doublet at δ 4.03, J = 9.8, 4.3 Hz 
was due to C-3 proton, bonded to acetoxy group. The coupling constant along with chemical shift describes the 
absolute configuration of acetoxy group, β and equatorial at C-3. The recorded data of 2 is comparable with the 
data reported for lupeol acetate in the  literature20.
Compound 3. HR-EI-MS spectrum showed  [M]+ at 442.3819 deduced for molecular formula  C30H50O2 
depicted six degrees of unsaturation. 1H-NMR spectrum showed δ at 3.25 (dd, J, 11.4, 5.2 Hz) was attributed due 
to H-3 germinal to _OH proton. Two broad singlets appeared at δ 4.46 and 4.92 (br s, 1H each) were assigned 
to terminal isopropenyl group. Six tertiary methyl singlets were observed at δ (0.86, 0.83, 0.84, 0.87, 1.02, 1.04) 
were assumed for methyl protons of (H-23, H-24, H-25, H-26, H-27 and H-30). One doublet appeared at δ 3.40 
and 3.71 (2H, d, J = 11.2 Hz) was due to methylene protons of C-28. Compound 3 can be identified as  Betulin21.
Compound 4. HR-EI-MS spectrum showed  [M]+ at 414.3838, correlated with molecular formula  C29H50O 
(calcd. m/z: 414.3661). Characetristic fragment ions m/z 414 and 396 in EI-MS spectrum also confirmed 
β-sitosterol pattern. Similarly fragment ion m/z 255 was recorded due to loss of  [M+-side chain-H2O] and frag-
ments m/z: 329, 303 confirmed the diagnostic pattern for sterols with ∆5-unsaturation. The 1H-NMR spectrum 
also confirmed the characteristic steroid pattern, one triplet at δ 5.41 (J = 3.2 Hz) was assigned for olefinic proton 
of C-6 and a carbinylic signal was recorded at δ 3.45 (1H, m). Some doublet signals appeared at δ 0.902 (J = 6.4), 
0.86 (J = 6.6), 0.82 (J = 6.6), 0.89 (J = 6.8) and were recommended for C-21, 26, 27 and C-29 methyl protons. The 
13C-NMR spectrum of compound 4 showed 29 carbons with 6 methyl, 11 methylene, 9 methine and 3 quaternary 
carbon atoms. The compound 4 was identified as β-sitosterol, also confirmed by reported data in  literature22.
Compound 5. HR-EI-MS showed  M]+ at m/z 426.3534, established molecular formula  C30H50O, calculated by 
426.3860. Eight tertiary methyl protons were identified in the 1H NMR spectrum (500 MHz,  CD3OD) δ 0.80, 
0.84, 0.88, 0.95, 1.12, 1.34, 1.01 and 1.11, each (3H, s). C-12 olefinic proton was also indicated at δ 5.22 (1H, br, 
s) and a double doublet at δ 3.61 (1H, dd, J = 8, 4.4 Hz) was due to C-3 proton. The 13C NMR (BB and DEPT) 
spectrum showed presence of 8 –CH3, 10 –CH2 , 5 –CH and 7-quaternary carbons. The spectroscopic data was 
identical with the data of well-known compound reported in the literature, commonly known as β-amyrin23.
Compound 6. HR-EI-MS spectrum showed the  [M]+ at m/z 456. 3671 recommended for  C30H48O3 calculated 
for 456.3603. EI-MS spectrum in addition to recording molecular ion peak m/z 456 showed characteristic frag-
ment ions m/z 248, 203 and 133 for ∆12 amyrin skeleton. The 1H NMR spectrum displayed the signal for olefininc 
proton at δ 5.18 (1H, br s, H-12) and oxymethine proton germinal to hydroxyl group at δ 3.14 (1H, dd, J = 10, 
5.5 Hz). Seven singlets were also showed for seven methyl group protons were recorded at δ (1.19, 1.02, 0.92, 
0.88, 0.80, 0.74 and 0.71). 13C NMR spectrum showed 30 carbon signals comprising of 7 –CH3, 10 –CH2, 5 –CH 
and 8 –C carbon atoms. Carbonyl carbon showed prominent signal at δ 180.8, olefinic carbons δ 124.4 and 
oxymethine carbon δ 78.2. The above spectral data for compound 6 was in complete agreement Oleanolic  acid24.
Compound 7. HREI-MS spectrum showed  [M]+ at 168.1124 (calculated 168.1120) for  C8H8O4. In EI-MS spec-
tra base peak  [M]+ is represented at 168 and other peaks at 151 and 137 represent the loss of –OH and –OCH3 
groups. 1H-NMR spectrum (500 MHz,  CD3OD) of compound 7 presented a doublets at δ 6.80 (J = 8.2) and 
a dd at 7.55 with (J = 8.2 and 1.6 Hz) were assigned C-5 and C-6 protons. One proton doublet at δ 7.60 with 
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(J = 1.6 Hz), was assigned as C-2 proton. Singlet, three proton signal at δ 3.88 was attributed due to three protons 
of methoxy group. Another singlet at δ 4.59 was assigned to hydrogen of hydroxyl group. Compound 7 was thus 
identified as (4-hydroxy-3,5-dimethoxy benzoic acid) commonly known as vanillic acid. The 1H and 13C NMR 
spectroscopic data was also verified with the previous reported data for vanillic  acid25.
Compound 8. 1H-NMR spectrum of compound 8 showed presence of three aromatic hydrogens, which gives 
information that three positions of benzene ring might be substituted. Compound 8 gave one double doublet at 
δ 7.45 with (J = 8.2, 1.8 Hz) was assigned to C-6 proton due to possibility of ortho coupling with C-5 proton and 
meta coupling with C-2 proton. Two doublets appeared for single protons in aromatic region can be assigned 
to C-5 proton with (J = 8.2 Hz) due to ortho coupling with C-6 proton and to C-2 proton with (J = 1.8 Hz) due 
to meta coupling with C-6 proton respectively. H-decoupled 13C-NMR spectrum, seven peaks appeared for six 
non-equivalent carbons and one carboxylic carbon. The calculated mass for compound 18 with molecular for-
mula  C7H6O4 was 154.2338 and 154.2331 was observed again confirms the compound as protocatechuic  acid26.
Compound 9. Molecular ion peak  [M]+ was recorded at 286.0475 which is compatible for molecular formula 
 C15H10O6. EI-MS showed characteristic fragments at 257, 229, 213, 121,104, 93, 77 and 69. 1H NMR spectrum 
displayed two doublets at δ 8.03 and δ 6.92 representing AA’BB’ pattern for para-substituted benzene. Two meta 
coupled doublets also appeared at δ 6.42 and 6.18 with J = 1.8 Hz. Characteristic flavonoid signals 137.2, 146.2 
were shown clearly in 13C NMR (DEPT and BB) spectra. 13C NMR signals at δ 161.4, 160.2 and 114.2 represent 
the para-substituted benzene ring moiety. Similarly carbon atoms directly linked with oxygen displayed signals 
at 161.4, 103.4 and 160.2. The spectroscopic data was also matched with the reported data in literature and com-
pound (9) was identified as 3,4′,5,7-tetrahydroxyflavone commonly known as  kaempferol27.
Compound 10. Compound (10) HR-EI-MS spectra depicted molecular ion peak at m/z 302.0285 with rel-
evant molecular formula  C15H10O6. The 1H-NMR spectrum of (10) showed five signals each for five different 
aromatic protons. A doublet signal at 7.72 represents single proton in meta coupling with H-6′, 2.1 Hz might 
be attributed due to H-2′. A double doublet at 7.62 represents H-6′, in meta coupling with H-2′, J = 2.1 Hz and 
ortho coupling with H-5′, J = 8.4 Hz. Another doublet at 6.87 might be due to H-5′, J = 8.4. It suggested an ABC 
type-system having flavonol moiety with 3′, 4′-disubstituted B-ring. Similarly a pair of meta coupling protons 
signals at 6.17 (1H, d, J = 1.8, H-6) and 6.38 (1H, d, J = 1.8, H-8) were recorded for ring A. 13C-NMR spectra 
showed 15 signals having carbonyl signal at δ 170.5 for C-4. Five carbon nuclei attached to hydroxyl group gave 
five signals recorded at δC 137.1 (C-3), 160.9 (C-5), 165.1 (C-7), 146.4 (C-3′), 150.8 (C-4′) also supported the 
presence of 3,5,7,3′,4′-oxygenated flavone nucleus. The detailed studies on compound 10 were in consistent with 
the reported spectroscopic data, commonly known as  quercetin28.
Antifungal activity of fractions and isolated compounds. Different concentrations of methanolic 
extract suppressed fungal biomass by 34–49%. Likewise, there was 31–52%, 29–50%, 17–36% and 34–48% 
reduction in biomass of M. phaseolina due to different concentrations of methanolic n-hexane, chloroform, 
ethyl acetate and aqueous fraction of methanolic leaf extract, respectively (Fig. 1).
Antifungal activity of mencozeb and the ten isolated compounds against M. phaseolina is shown in Table 1. 
Fungicide mencozeb showed the highest antifungal activity causing 83–84% reduction in fungal biomass. In 
general, all the isolated compounds suppressed fungal growth variably and significantly. Out of the isolated 
compounds, lupeol acetate (2) showed the highest antifungal against M. phaseolina, causing 79–81% followed 
by betulin (3) 77–79% reduction in biomas of the target fungus, respectively. Other compounds showing pro-
nounced antifungal activities were β-amyrin (5), oleanolic acid (6), vanillic acid (7) and protocatechuic acid (8) 
that reduced fungal biomass by 68–71%, 68–71%, 74–79% and 67–72%, respectively. Compounds namely lupeol 
(1), β-sitosterol (4), kaempferol (9) and quercetin (10) were comparatively less antifungal and reduced fungal 
biomass by 40–43%, 57–64%, 46–53% and 47–55%, respectively over corresponding control.
Discussion
Identification of isolated compounds. From M. buxifolia methanolic extract ten compounds were iso-
lated from various sub-fractions. Various physical analysis and spectroscopic data co-ordinated from the already 
reported data and compound 1 was identified as lupeol, compound 2 as lupeol acetate, compound 3 as betulin, 
compound 4 as β-sitosterol, compound 5 as β-amyrin, compound 6 as oleanolic acid, compound 7 as vanillic 
acid, compound 8 as protocatechuic acid, compound 9 as kaempferol and compound 10 as  quercetin19–28 Struc-
tures of these compounds are presented in Fig. 2.
Antifungal potential of fractions and isolated compounds. All the concentrations of methanolic 
extracts and its various fractions significantly reduced fungal biomass. Antifungal activity of both compounds 
lupeol acetate (2) 79–81% and betulin (3) 77–79% were found very close to that of fungicide mancozeb 83–84%. 
Some earlier studies also reported antifungal activity of lupeol acetate (2) against Aspergillus flavus. However, 
most of the previous studies showed antibacterial activity of this compound against Bacillus subtilis, Staphylo-
coccus aureus and Escherichia coli29,30. In contrast to the present study, Manzano et al.31 reported no antifungal 
activity of 2 against Penicillium chrysogenum and Fusarium oxysporum, showing specificity of this compound 
against M. phaseolina. Betulin (3) has been reported fungicidal against a number of fungi including Fusarium 
solani and Aspergillus niger and its effect was equal to standard antifungal drug  miconazole32.
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β-Amyrin (5) is known to inhibit growth of various clinical fungal species namely Candida stellatoidea, 
Candida krusei, Microsporum sp. and Trichophyton rubrum and Ascochyta rabiei, the cause of blight disease of 
 chickpea33,34 Oleanolic acid (6) is a pentacyclic triterpenoid that is widely spread in plant kingdom, with mem-
bers of Oleaceae family as its main source. Apart from its various pharmaceutical properties, it also possesses 
antifungal activity against yeast and dermatophyte  species35,36. Protocatechuic acid (8) is a type of phenolic acid 
that is found in many food plants and possesses a number of pharmaceutical properties and antifungal activity 
against Microsporum audouinii37,38.
Figure 1.  (A–E) Effect of methanolic extract of Monotheca buxifolia and its fractions on biomass of 
Macrophomina phaseolina. Vertical bars show standard errors of means of three replicates. Values with different 
letters at their top show significant difference (P ≤ 0.05) as determined by Tukey’s HSD test.
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Methanolic extract 
fraction Conc. of DMSO (µL  mL−1)
Compound conc (mg 
 mL−1) Fungal biomass (mg) Decrease over control (%)
Control
0.104 0.0000 23.4 A –
0.208 0.0000 22.6 AB –
0.416 0.0000 22.8 AB –
0.832 0.0000 21.1 BC –
1.66 0.0000 21.3 B –
3.33 0.0000 21.0 BC –
6.66 0.0000 19.2 C –
Mencozeb
0.104 0.0312 3.9 Za–e 83
0.208 0.0625 3.7 a–e 84
0.416 0.1250 3.8 a–e 83
0.832 0.2500 3.5 d–e 83
1.66 0.5000 3.5 b–e 83
3.33 1.0000 3.3 c–e 85
6.66 2.0000 3.1 e 84
Lupeol (1)
0.104 0.0312 13.3 DE 43
0.208 0.0625 13.4 D 41
0.416 0.1250 13.4 D 41
0.832 0.2500 12.8 D–F 39
1.66 0.5000 12.3 D–G 42
3.33 1.0000 12.5 D–G 40
6.66 2.0000 11.6 D–H 40
Lupeol acetate (2)
0.104 0.0312 4.6 T-Za–e 80
0.208 0.0625 4.6 T-Za–e 80
0.416 0.1250 4.3 V-Za–e 81
0.832 0.2500 4.3 V-Za–e 80
1.66 0.5000 4.0 Y-Za–e 81
3.33 1.0000 3.9 Za–e 81
6.66 2.0000 4.0 Y–Za–e 79
Betulin (3)
0.104 0.0312 5.7 O–Za 76
0.208 0.0625 5.3 P–Za–c 77
0.416 0.1250 5.2 P–Za–d 77
0.832 0.2500 4.5 U–Za–e 79
1.66 0.5000 4.7 S–Za–e 78
3.33 1.0000 4.5 U–Za–e 79
6.66 2.0000 4.2 X–Za–e 78
β-Sitosterol (4)
0.104 0.0312 9.4 I–K 60
0.208 0.0625 9.4 I–K 58
0.416 0.1250 9.0 J–L 61
0.832 0.2500 9.1 J–L 57
1.66 0.5000 8.0 K–M 62
3.33 1.0000 7.7 K–N 64
6.66 2.0000 7.7 K–N 60
β-Amyrin (5)
0.104 0.0312 7.4 L–O 68
0.208 0.0625 6.9 M–Q 69
0.416 0.1250 6.5 M–U 71
0.832 0.2500 6.6 M–T 69
1.66 0.5000 6.6 M–T 69
3.33 1.0000 6.2 M–X 70
6.66 2.0000 6.2 M–X 68
Oleanolic acid (6)
0.104 0.0312 6.8 M–R 71
0.208 0.0625 6.7 M–S 70
0.416 0.1250 6.7 M–S 71
0.832 0.2500 6.3 M–V 70
1.66 0.5000 6.5 M–U 69
3.33 1.0000 6.3 M–V 70
6.66 2.0000 6.0 N–Y 68
Continued
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Lupeol (1), a pentacyclic triterpenoid, has also been isolated from a number of plant species including green 
pepper, mangoes, strawberry, grapes, white cabbage and olive, and is known to have useful effect as a preventive 
and therapeutic agent against a number of  ailments39. Although in the present study, it found comparatively 
less effective against M. phaseolina, however, it was highly effective against Penicillium notatum causing 90% 
growth inhibition when used in 200 µg  mL−1  concentration31. It was also inhibitory to the growth of Fusarium 
solani, Aspergillus niger, Rhizoctoia phaseoli, Candida albicans, Penicillium chrysogenum, Cantharellus flavus and 
Microsporum canis, and its antifungal activity was comparable with  miconazole40. β-Sitosterol (4) is known to 
inhibit growth of Aspergillus niger and Cladosporium cladosporioides at a concentration of 0.01 mg  mL−1. It also 
inhibited growth of germ tube of Fusarium verticillioides by 82% at 50 mg  mL−141. Quercetin (10) is a polyphenolic 
flavonoid and showed a low activity against different Candida  species42. This compound is also known to increase 
efficacy of a fungicidal compound amphotericin B against a clinical fungal species Cryptococcus neoformans43. 
Kaempferol (9) is a phenolic compounds generally showing antibacterial  activity44. Information regarding its 
antifungal activity are very rare. The present study concludes that aerial parts of M. buxifolia contain potentent 
antifungal constituents especially lupeol acetate (2) causing 79–81% reduction followed by betulin (3) 77–79% 
and vanillic acid (7) 74–79% for the management of M. phaseolina, a highly problematic phytopathogen for 
which there is not any registered fungicides so far.
Materials and methods
Chemicals and reagents. Chemicals were attained from Sigma-Aldrich Germany. For isolation work 
including chromatography various solvents were acquired from Fischer Scientific (Loughborough, UK). Silica 
and Flash column silica (70–230 mesh) and (230–400 mesh) were assimilated from E. Merck, Darmstadt, Ger-
many.
Methanolic extract 
fraction Conc. of DMSO (µL  mL−1)
Compound conc (mg 
 mL−1) Fungal biomass (mg) Decrease over control (%)
Vanillic acid (7)
0.104 0.0312 6.2 M–X 74
0.208 0.0625 5.6 O–Za 76
0.416 0.1250 5.6 O–Za 79
0.832 0.2500 5.4 O–Zab 74
1.66 0.5000 4.7 S–Za–e 78
3.33 1.0000 4.9 R–Za–e 77
6.66 2.0000 4.9 R–Za–e 74
Protocatechuic acid (8)
0.104 0.0312 6.9 M–Q 71
0.208 0.0625 6.7 M–S 70
0.416 0.1250 6.9 M–Q 70
0.832 0.2500 6.9 M–Q 67
1.66 0.5000 6.5 M–U 72
3.33 1.0000 6.2 M–X 70
6.66 2.0000 5.9 N–Z 69
Kaempferol (9)
0.104 0.0312 12.3 D–G 50
0.208 0.0625 11.6 D–H 50
0.416 0.1250 11.3 E–I 50
0.832 0.2500 11.3 E–I 46
1.66 0.5000 10.8 G–J 58
3.33 1.0000 9.0 J–L 57
6.66 2.0000 9.1 J–L 53
Quercetin (10)
0.104 0.0312 12.0 D–H 49
0.208 0.0625 12.0 D–H 47
0.416 0.1250 11.8 D–H 48
0.832 0.2500 11.2 F–I 47
1.66 0.5000 10.1 H–J 53
3.33 1.0000 9.5 I–K 55
6.66 2.0000 9.0 J–L 53
HSD0.001 2.01
Table 1.  Effect of different concentrations of fungicide mancozeb and compounds isolated from Monotheca 
buxifolia on growth appearance and biomass of Macrophomina phaseolina. Values with different letters in a 
column show significant difference (P ≤ 0.001) as determined by Tukey’s HSD test.
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Physical parameters and spectroscopic analysis. Melting point apparatus Buchi 535 was used to 
record melting point. Digital Polarimeter; Jasco DIP-360 was used to record optical rotation. Shimadzu UV-240 
spectrophotometer was used to record λmax in nm. Infrared spectra (IR) were recorded on Shimadzu IR-460 in 
nujol or KBr pellets and reported in  cm−1. NMR spectra were recorded on Bruker AMX-500 and AM-400  for1H 
(300–500 MHz)  and13C (125–150 MHz) spectrometers. "spectra were recorded on Bruker Avance spectrometers 
ranging from 7.05 up to 14.09 T". Mass spectrometer Jeol-JMS H X-110 was employed to record high resolution 
electron ionization mass spectra (HR-EIMS).
Figure 2.  Structures of compounds isolated from n-hexane (1 and 2), chloroform (3–6) and ethyl acetate 
(7–10) fraction of methanolic extract of Monotheca buxifolia.
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Collection, extraction and fractionation from plant material. M. buxifolia is wild and commonly 
grown plant species in mountains of Swat, Pakistan. Aerial parts viz., stem and leaves (11 kg) of M. buxifolia 
were collected from Swat, Pakistan according to prescribed rules in The Pakistan Trade Control of Wild Fauna 
and Flora Act, 2012. Species was identified by Dr. Arshad Javaid (Associate Professor, Institute of Agricultural 
Sciences, University of the Punjab, Lahore, Pakistan), assigned voucher no. GC. Bot. Herb. 815 (Monotheca buxi-
folia) and was deposited in the Dr. Sultan Ahmed Herbarium, Department of Botany, GC University, Lahore, 
Pakistan.
Aerial parts were dried under shade, pulverized and weighed (4.5 kg). Powdered plant material was soaked 
in MeOH 95% (16 L × 4). Extracts were assembled and methanol was removed under reduced pressure at 50 °C 
temperature. Gummy mass (586 g) having dark brown colour was collected. This MeOH extract was added in 
water (410 mL) and further fractionation was done using n-hexane, chloroform and ethyl acetate (10 × 3 L) 
each to afford 151, 102 and 152 g of the fractions respectively. Aqueous fraction was collected 161 g and all the 
portions were  refrigerated17.
Isolation of Macrophomina phaseolina. Diseased root pieces of mungbean were collected, washed and 
cut into small pieces of 0.5 cm. Root pieces were surface sterilized using 0.1% sodium hypochlorite solution, 
transferred aseptically on autoclaved malt extract agar plates and incubated for 7 days at 27 °C. Grey fungal colo-
nies appeared on root pieces which became darken with time. The colonies were further purified by growing on 
fresh malt extract agar plates. The fungus was isolated and identified as M. phaseolina (FCBP-0751) on the basis 
of characteristic black-colored oblong  microsclerotia18.
Antifungal bioassays with M. buxifolia extract/fractions. The methanolic extract and its four frac-
tions were tested against the pathogenic fungus M. phaseolina in vitro. An amount of 1.2 g of methanolic extract 
and its various fractions was dissolved in 1 mL of dimethyl sulphoxide (DMSO) and added to 5 mL autoclaved 
malt extract broth to make stock solution of 200 mg   mL−1 concentration. Six lower concentrations viz. 100, 
50, 25, 12.5, 6.25 and 3.125 mg  mL−1 were prepared from stock solution in series of double dilution. Similarly, 
control with respect to each concentration was prepared by dissolving 1 mL DMSO in 5 mL malt extract broth 
and double diluted in series. Experiment was performed in glass test tubes (10 mL), each containing 1 mL of 
growth medium. Tubes were inoculated aseptically with 20 µL of M. phaseolina suspension and each treatment 
was replicated three times. After 7 days of incubation at room temperature, fungal biomass was filtered, dried 
and weighed.
Isolation and purification of compounds. M. buxifolia lipophilic hexane fraction was subjected to vac-
uum liquid chromatography over silica gel and eluted with increasing order of solvent polarity as hexane–EtOAc 
(0 → 10). Hexane first sub-fraction, collected using n-hexane: EtOAc (7:3) was again chromatographed to isolate 
compound 1 (10 mg) using same polarity system. Hexane second sub-fraction collected using n-hexane–EtOAc 
(6:4) was again chromatographed to isolate compound 2 (8 mg) eluted with same solvent system.  CHCl3 fraction 
was subjected to silica gel column and eluted with n-hexane-chloroform (10:0 → 0:0) to chloroform–methanol 
(0:0 → 0:10). Chloroform fraction lead to isolation of three main sub-fractions.  CHCl3 sub-fraction 1 was fur-
ther purified and compound 3 and 4 (13,10 mg) were obtained with n-hexane-CHCl3 (7:3) n-hexane-dichlo-
romethane (5:5) and (6:4) as eluent, respectively. Sub-fraction 2 eluted with n-hexane-chloroform (6:4) was 
purified with n-hexane:dichloromethane (5:5) to obtain compound 5 (15 mg).  CHCl3 sub-fraction 3 eluted with 
chloroform–methanol (9.5:0.5) was rechromatographed using dichloromethane-methanol (9:1) to afford com-
pound 6 (30 mg). The EtOAc fraction was chromatographed using silica gel and eluted with solvent system of 
increasing polarity n-hexane, n-hexane: DCM and DCM:MeOH and three sub-fractions were collected. EtOAc 
sub-fraction 1, eluted by n-hexane: DCM (3:7) was refilled on silica gel and eluted by n-hexane:DCM (1:9) to 
attain compound 4 (4 mg) and 7 (6 mg). EtOAc sub-fraction 2 eluted by DCM 100%, was reloaded and eluted 
by same solvent system to separate compound 8 (8 mg). EtOAc sub-fraction 3 was isolated using DCM:MeOH 
(9:1) was rechromatographed and eluted with identical solvent system to collect compound 9 and 10 (6,8 mg).
Physical properties, spectral analysis of pure compounds. Lupeol (1). Melting point, 215 °C was 
recorded. 1H-NMR (400 MHz,  CD3OD), δ ppm: 4.20 and 4.21 (2H, br, 1H each, H-29), 3.30 (1H, dd, J = 9.4, 
4.6 Hz, H-3), 0.74, 0.81, 0.85, 0.89, 0.91, 0.97, 1.06 (3H, 7 s, 7 Me). 13C-NMR (150 MHz, CD3OD) δ ppm: 150.7 
(C-20), 109.7 (C-29), 79.2 (C-3), 55.2 (C-5), 50.3 (C-9), 48.3 (C-18), 47.8 (C-19), 43.2 (C-17), 42.7 (C-14), 40.7 
(C-8), 39.9 (C-22), 38.6 (C-4), 38.2 (C-1), 38.0 (C-13), 37.3 (C-10), 35.9 (C-16), 35.0 (C-7), 29.7 (C-21), 28.4 
(C-22), 28.2 (C-23)27.9 (C-2), 27.2 (C-15), 25.3 (C-12), 21.1 (C-11), 19.3 (C-30), 18.4 (C-6), 18.2(C-28), 15.8 
(C-25), 15.5 (C-26), 15.3 (C-27), 15.1 (C-24). EI-MS m/z  [M]+ at : 426.
Lupeol acetate (2). IR spectrum showed absorption at 1730  cm−1. 1H-NMR (500 MHz,  CD3OD), δ ppm: 4.47 
and 4.44 (2H, br, 1H each, H-29), 4.03 (1H, dd, J = 9.8, 4.3 Hz, H-3), 0.76, 0.81, 0.83, 0.86, 0.92, 1.01, 1.31 (3H, 
7 s, 7 Me) and 2.32 (3H,s,  CH3COO). 13C- NMR (150 MHz,  CDCl3) δ ppm: 172.2 (C-1′), 150.2 (C-20), 110.5 
(C-29), 81.1 (C-3), 50.7 (C-9), 48.7 (C-18), 48.4 (C-19), 38.5 (C-1), 22.7 (C-2), 37.2 (C-4), 55.3 (C-5), 18.3 (C-6), 
34.8 (C-7), 41.2 (C-8), 40.1 (C-22), 37.2 (C-10), 21.2 (C-11), 24.6 (C-12), 37.2 (C-13), 43.0 (C-14), 26.4 (C-15), 
35.8 (C-16), 43.1 (C-17), 29.9 (C-21), 28.2 (C-23), 20.4 (C-2′), 19.3 (C-30),16.1 (C-24), 16.3 (C-25), 15.4 (C-26), 
14.2 (C-27), 14.8 (C-28). EI-MS m/z  [M]+ at : 468.
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Betulin (3). Compound 3 showed IR spectrum at 3457  cm−1. 1H-NMR (500 MHz,  CDCl3), δ ppm: 4.46 and 
4.92 (br s, 1H each, H-29), 3.40 and 3.71 (2H, d, J = 11.2 Hz, H-28), 3.25 (dd, J = 11.4, 5.2 Hz, H-3), 0.83  (H3-24), 
0.84  (H3-25), 0.86  (H3-23), 0.87  (H3-26), 1.02  (H3-27), 1.04  (H3-30) (3H, 6  s, 6 Me). 13C- NMR (150  MHz, 
 CDCl3) δ ppm: 150.8 (C-20), 109.8 (C-29), 79.1 (C-3), 60.4 (C-28), 38.4 (C-1), 55.3 (C-5), 50.6 (C-9), 48.6 
(C-19), 46.6 (C-17), 42.5 (C-18), 42.8 (C-14), 27.5 (C-2), 39.2 (C-4), 37.5 (C-13), 36.2 (C-22), 30.2 (C-21), 18.4 
(C-6), 34.3 (C-7), 39.5 (C-8), 37.2 (C-10), 21.0 (C-11), 24.2 (C- 12), 27.2 (C-15), 30.3 (C-16), 28.1 (C-23), 19.1 
(C-30), 16.1 (C-25), 16.2 (C-26), 15.2 (C-24), 14.8 (C-27). EI-MS m/z  [M]+ at : 442.
β-sitosterol (4). 1H-NMR (500 MHz,  CDCl3), δ ppm: 5.41 (1H,t, J = 3.2 Hz, H-6), 3.45 (1H, m, H-3), 1.034 (3H, 
s, Me-19), 0.902 (3H,d,J = 6.4, Me-21), 0.89 (3H ,d,J = 6.8, Me-29), 0.86 (3H,d, J = 6.6, Me-26), 0.82 (3H,d,J = 6.6, 
Me-27), 0.68 (3H,s, Me-18). 13C-NMR (150 MHz,  CDCl3) δ ppm: 141.2 (C-5), 122.1 (C-6), 72.2 (C-3), 56.8 
(C-14), 56.2 (C-17), 51.9 (C-9), 46.4 (C-24), 42.4 (C-4), 41.8 (C-13), 40.6 (C-12), 36.8 (C-1), 35.8 (C-10), 34.4 
(C-20), 32.2 (C-22), 31.8 (C-7), 31.6 (C-8), 31.2 (C-2), 30.4 (C-25), 28.6 (C-16), 25.4 (C-23); 24.8 (C-15), 23.8 
(C-28), 22.8 (C-11), 21.2 (C-26), 20.6 (C-19), 19.8 (C-27), 18.9 (C-21), 12.8 (C-29), 12.6 (C-18). EI-MS m/z  [M]+ 
at : 414.
β-amyrin (5). Absence of absorption in UV region was indicated. 1H-NMR (500 MHz,  CD3OD), δ ppm: 5.22 
(1H, br s, H-12), 3.61 (1H, dd, J = 8, 4.4 Hz, H-3), 0.80 (3H, s), 0.84 (3H, s), 0.88 (3H, s), 0.95 (3H, s), 1.12 (3H, 
s), 1.34 (3H, s) , 1.01 (3H, s) and 1.11 (3H, s). 13C-NMR (150 MHz,  CDCl3) δ ppm: 145.6 (C-13), 121.4 (C-12), 
78.8 (C-3), 47.2 (C-18), 46.6 (C-19), 37.8 (C-1), 28.1 (C-2), 38.4 (C-4), 55.6 (C-5), 18.8 (C-6), 33.1 (C-7), 38.2 
(C-8), 47.8 (C-9), 37.2 (C-10), 23.4 (C-11), 41.2 (C-14), 26.8 (C-15), 27.3 (C-16), 32.2 (C-17), 31.1 (C-20); 34.2 
(C-21), 37.3 (C-22), 28.9 (C-23), 15.5 (C-24), 15.6 (C-25), 16.7 (C-26), 26.4 (C-27), 28.8 (C-28), 33.4 (C-29), 23.8 
(C-30). EI-MS m/z  [M]+ at : 426.
Oleanolic acid (6). IR spectrum showed absorption band 3430–2650, 1680 and 1650–850  cm- respectively.1H-
NMR (500 MHz,  CDCl3), δ ppm: 5.18 (1H, br s, H-12), 3.14 (1H, dd, J = 10, 5.5 Hz, H-3), 1.19 (3H, s), 1.02 (3H, 
s), 0.92 (3H, s), 0.88 (3H, s), 0.80 (3H, s), 0.74 (3H, s) and 0.71 (3H, s). 13C-NMR (150 MHz,  CDCl3) δ ppm: 180.8 
(C-28), 145.8 (C-13), 124.4 (C-12), 78.2 (C-3), 55.9 (C-5), 48.5 (C-9), 47.2 (C-17), 46.6 (C-19), 42.5 (C-18), 42.4 
(C-14), 39.4 (C-4), 38.8 (C-1), 33.8 (C-29), 33.3 (C-7), 40.1 (C-8), 37.1 (C-10), 31.4 (C-20); 34.8 (C-21), 33.1 
(C-22), 29.8 (C-23), 24.1 (C-11), 28.8 (C-15), 28.2 (C-2), 26.8 (C-27), 24.2 (C-16), 23.6 (C-30), 19.1 (C-6), 17.2 
(C-26), 16.4 (C-24), 16.1 (C-25). EI-MS m/z  [M]+ at : 456.
Vanillic acid (7). The UV λmax showed absorption at 282  nm. The infrared spectrum displayed absorption 
bands at 3400–2700 and 1670  cm−1 indicated the presence of conjugated carboxylic acid. 1H-NMR (500 MHz, 
 CD3OD), δ ppm: 7.60 (1H, d, 1.6 Hz, H-2), 7.55 (1H, dd, J = 8.2, 1.6 Hz, H-6), 6.80 (1H, d, J = 8.2, H-5), 4.59 
(1H,s, OH), 3.88 (3H, s,  OCH3). 13C- NMR (150 MHz,  CD3OD) δ ppm: 55.9  (CH3O-3), 112.3 (C-2), 114.3 (C-5), 
121.9 (C-6), 124.0 (C-1), 146.6 (C-3), 150.5 (C-4). EI-MS m/z  [M]+ at : 168.
Protocatechuic acid (8). UV absorption was recorded at 274 nm, IR spectrum displayed absorption bands at 
3210–2610  cm−1. 1H-NMR (500 MHz,  CD3OD), δ ppm: 7.45 (1H, dd, J = 8.2, 1.8 Hz, H-6), 7.42 (1H, d, J = 1.8 Hz, 
H-2), 6.82 (1H, d, J = 8.2 Hz, H-5), 13C- NMR (150 MHz,  CDCl3) δ ppm: 123.4 (C-1), 120.9 (C-2), 147.2 (C-3), 
148.9 (C-4), 117.4 (C-5), 118.5 (C-6), 170.5 (C-7). EI-MS m/z  [M]+ at : 154.
Kaempferol (9). Melting point at 276–278 °C was recorded. UV spectrum recorded λmax at 265, 212 and 336 
(4.0) nm while IR spectrum showed absorption at 3412, 2926, 1660, 1610, 1600–1525 and 1380  cm−1. 1H-NMR 
(400 MHz, DMSO), δ ppm: 8.03 (2H, d, J = 8.8 Hz, H-2′, -6′), 6.92 (2H, d, J = 8.8 Hz, H-3′,-5′), 6.42 (1H, d, 
J = 1.8 Hz, H-8), 6.18 (1H, d, J = 1.8 Hz, H-6).13C- NMR (150 MHz, CD3OD) δ ppm: 178.1 (C-4), 161.4 (C-5), 
160.2 (C-7), 159.4 (C-4′), 155.9 (C-9), 146.2 (C-2), 137.2 (C-3), 128.3 (C-2′, -6′), 121.3 (C-1′), 114.2 (C-3′, -5′), 
103.4 (C-10), 99.8 (C-6), 93.4 (C-8). EI-MS m/z  [M]+ at : 286.
Quercetin (10). Melting point was recorded at 314–316 °C. Two characteristic absorption bands in UV spec-
trum at 250 and 360 nm were showed. HR-EI-MS spectra depicted molecular ion peak at m/z 302.0285 with 
relevant molecular formula  C15H10O6. IR spectrum showed two characteristic bands at 3402 and 1610   cm−1. 
1H-NMR (300 MHz,  CD3OD), δ ppm: 7.72 (1H, d, 2.1 Hz, H-2′), 7.62 (1H, dd, J = 8.4, 2.1 Hz, H-6′), 6.87 (1H, 
d, J = 8.4, H-5′), 6.38 (1H, d, J = 1.8, H-8), 6.17 (1H, d, J = 1.8, H-6). 13C-NMR (150 MHz, CD3OD) δ ppm: 170.5 
(C-4), 165.1 (C-7), 160.9 (C-5), 160.0 (C-9), 150.8 (C-4′), 146.4 (C-3′),146.2 (C-2), 137.1 (C-3), 124.2 (C-1′), 
121.4 (C-6′)117.0 (C-2′,-5′), 104.2 (C-10), 99.2 (C-6), 94.1 (C-8). EI-MS m/z  [M]+ at : 302.
Antifungal bioassays with pure compounds from M. buxifolia. Two compounds (1, 2) were iso-
lated from n-hexane fraction, four compounds (3–6) from chloroform fraction and four compounds (7–10) 
from ethyl acetate fraction of the methanolic extract of M. buxifolia were tested for MIC values by microdilution 
assay. MIC values of mancozeb as reference synthetic fungicide (80%WP, KSS) and isolated compounds were 
tested by serial dilution in culture tubes. Six milligrams of each of the ten isolated compounds and mancozeb 
(active ingredient) were dissolved in 20 µL DMSO and added to autoclaved malt extract to raise the volume up 
to 3 mL, to prepare a growth medium of 2 mg  mL−1 concentration. Further serial double dilutions viz. 1, 0.5, 
0.25…0.0312 mg  mL−1 were made using malt extract broth in culture tubes. Spore suspension was prepared by 
adding 10 day old fungal culture in double distilled water. DMSO (20 µL mL) was added in malt extract broth 
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to prepare 3 mL of control that serially double diluted to make corresponding control treatments for each con-
centration. Each treatment was replicated thrice. Fugal suspension (20 µL) was added to each concentration 
(0.5 mL) of the growth medium and incubated at 27 °C. Fungal biomass was collected on filter papers after 3 days 
growth, dried and weighed.
Statistical analysis. All the data were analyzed by analysis of variance followed by Tukey’s HSD Test using 
computer software Statistix 8.1.
Ethics approval. This article does not contain any studies with human participants or animal experiments.
Received: 15 December 2020; Accepted: 1 April 2021
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